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Abstract
Background: Reliable HIV incidence estimates for Mozambique are limited. We conducted a prospective HIV incidence
study as part of a clinical research site development initiative in Chókwè district, Gaza Province, southern Mozambique.
Methods: Between June 2010 and October 2012, we recruited women at sites where women at higher risk of HIV infection
would likely be found. We enrolled and tested 1,429 sexually active women in the screening phase and 479 uninfected
women in the prospective phase. Participants were scheduled for 12+months follow-up, when they underwent face-to-face
interviews, HIV counseling and testing, and pregnancy testing. We observed a total of 373.1 woman-years (WY) of follow-up,
with mean (median) of 9.4 (9.7) women-months per participant.
Results: The prevalence of HIV was 29.4% (95% confidence interval [CI]: 27.0–31.8%). In multivariable logistic regression
analysis, factors that remained significantly associated with prevalent HIV were: older age (OR: 0.6; 95% CI: 0.4–0.7), lower
educational level (OR: 0.4; 95% CI: 0.3–0.7), and using hormonal contraception (OR: 0.6; 95% CI: 0.4–0.7) or condoms (OR: 0.5;
95% CI: 0.3–0.7). We observed an HIV incidence rate of 4.6 per 100 WY (95% CI: 2.7, 7.3). The HIV incidence was 4.8 per
100 WY (95% CI: 2.5, 8.3) in women aged 18–24 years, 4.5 per 100 WY (95% CI: 1.2, 11.4) in women aged 25–29 years and
3.2 per 100 WY (95% CI: 0.1, 18.0) in the 30–35 years stratum. None of the demographic factors or time-varying behavioral
factors examined was significantly associated with incident HIV infection in bivariable analysis at p#0.10.
Conclusions:We found a high HIV incidence among sexually active young women in Chókwè, Mozambique. HIV prevention
programs should be strengthened in the area, with more comprehensive reproductive health services, regular HIV testing,
condom promotion, and messaging about multiple sexual partners.
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Introduction
Mozambique, located in southeast Africa, has one of the world’s
highest HIV/AIDS burdens, with 1.2 million people infected at
the end of 2011 [1]. HIV prevalence increased dramatically
nationwide through the 1990s and has stabilized at a high rate. By
2009, 23 years after the first case of HIV was diagnosed there, the
national adult HIV/AIDS prevalence was 11.5% [2], with the
majority of new HIV infections acquired through heterosexual
contact. According to 2009 national surveillance data, Gaza
Province in the south had the highest HIV prevalence in the
country at 29.9% among women 15–49 years old and 16.8%
among men the same age (25.1% overall [2]. The percentage of
women aged 15–49 years old that received an HIV test in the past
year was 26%, compared to 10% of men of the same age [2].
HIV incidence data are scant in Mozambique. We conducted a
cross-sectional screening and prospective cohort study of HIV in
Chókwè, Gaza Province, southern Mozambique as part of a site
development initiative to assess the feasibility of and build the
capacity for HIV prevention research. We report here the HIV
prevalence and incidence results and risk factors for HIV in a
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cohort of women recruited at venues where those at higher risk of
HIV would likely be found.
Methods
The study was conducted at the Chókwè Health Research and
Training Center (CITSC) in Chókwè city, a research unit affiliated
with the Mozambican National Institute of Health (INS). The
study was done in collaboration with FHI 360 and the United
States Military HIV Research Program (MHRP). Chókwè district
is located in Gaza Province along the Limpopo River in the
southern region of the country, about 220 kilometers northwest of
Maputo, and is home to about 200,000 people, nearly half of
whom reside in Chókwè city, where recruitment and enrollment
were focused. The city is the center for the surrounding
agricultural area which includes subsistence farmers as well as a
major irrigation system supporting large rice production enter-
prises.
Study Design and Population
Women identified as potentially at higher risk of HIV infection
were invited to enroll in the study. Over 1,400 women were
screened in a cross-sectional study that served as the screening
phase for the prospective study. We invited HIV-negative women
to enroll in the prospective phase, which involved monthly follow-
up visits for up to 12 months.
The primary objective of the study was to measure prospectively
the incidence of HIV infection. A secondary objective was to assess
the site’s ability to enroll and retain the cohort for one (and later
two) year(s). Inclusion criteria were: women aged 18 to 35 years;
HIV-negative by rapid testing; sexually active in the last month;
willing to adhere to study visit requirements; and planning to
reside in Chókwè for the duration of the study. Women were
excluded if they had a medical condition that precluded their
participation in the study. Pregnancy was not an exclusion
criterion.
Mid-way through the study, we amended the protocol to
increase the study size, lengthen the total duration of follow-up to
24 months per participant, and change the frequency of follow-up
visits to every three months. The study size was increased to
provide more precision around possible lower incidence ranges,
and the follow-up schedule was modified to mimic better the likely
design of future HIV vaccine trials. But the study was terminated
early for logistical and financial reasons unrelated to study
performance.
Recruitment Procedures
Prior to study initiation, community sensitization activities were
carried out, consisting of informational meetings with the Chókwè
district and health authorities, numerous bairro (neighborhood)
leaders and community members. Potential participants were
recruited in various community venues in Chókwè city (markets,
nightclubs, bars, hotels), as well as secondary schools, where we
would be likely to find young women who engage in risky sexual
behavior. Interested women were approached by field workers
who explained more about the study objectives and procedures.
Volunteers were given an appointment card and invited to visit the
Chókwè Health Research and Training Center (CITSC) for
screening. Informed consent was administered, and HIV and
pregnancy testing along with interviewing ensued. To enhance
follow-up in the prospective phase, we contacted participants
before their scheduled visit dates, as well as after missed visits.
Data Collection and Study Procedures
Data collection took place between June 2010 and October
2012 at the CITSC adjacent to the Chókwè District Hospital. We
collected baseline, demographic, behavioral, and clinical data and
performed counseling and rapid testing for HIV and pregnancy.
Counseling and HIV and pregnancy testing were repeated at each
follow-up visit, along with behavioral interviews. Participants
received condoms free of charge at each visit, and were given 150
Meticais reimbursement (about USD $5) to compensate for missed
income and transport costs. Women found to be HIV-infected,
pregnant or suspected of having a sexually transmitted infection
(STI) were referred for care in the nearby public clinics.
Data were double-entered on-site into a ClinTrial database
(Oracle Health Sciences, Redwood Shores, CA, USA) and
transmitted to the FHI 360 server using Title 21 Code of Federal
Regulations Part-11 compliant Citrix 12.3 software.
Laboratory Testing
We performed serial rapid HIV testing first with the Determine
HIV-1/2 test (Alere Medical Co. Ltd., Chiba, Japan), with
reactive results followed with Uni-Gold Recombigen HIV test
(HIV Trinity BioTech PLC, Bray, Ireland), per Mozambique’s
national HIV testing algorithm. We used parallel SD Bioline HIV-
1/2 version 3.0 test (Standard Diagnostics Inc., Kyonggi-do,
Korea) and Vironostika HIV-1 ELISA testing (Uni-Form II Plus 0
test, BioMerieux BV, Boxtel, The Netherlands) to resolve
discrepant results. We stored aliquots of plasma at 280uC to
allow confirmation of possible HIV seroconversion events.
Incident HIV infection was defined as two positive rapid HIV
antibody tests or one positive HIV rapid test confirmed by positive
ELISA Vironostika test, after negative results at the previous visit.
All incident HIV infections were confirmed by quantitative HIV-1
RNA PCR with stored specimens at the national reference
laboratory of the INS in Maputo. Urine pregnancy testing was
done using a rapid human chorionic gonadotropin (hCG) test
(Healthease Preg n Care, NEOMED IPA, Tzaneen, South Africa).
Statistical Analysis
The prospective cohort study was designed to enroll approxi-
mately 400 women and observe at least 380 person-years of follow-
up to conclude that the HIV incidence is no less than 2.1% (two-
sided a= 0.05) if the observed incidence was 4.2 per 100 person-
years. The mid-study protocol amendment intended to demon-
strate the feasibility of future HIV vaccine trials called for an
increased study size of 735 participants, which was not achieved
due to funding constraints.
We summarized baseline variables using descriptive statistics
expressed as mean or median for continuous variables and
percentages for categorical variables. In the prospective phase,
HIV-negative participants were censored on the date of the last
follow-up visit. For HIV seroconvertors, we estimated the date of
seroconversion as the midpoint between the last HIV RNA PCR
negative and the first HIV RNA PCR positive test result during
the follow-up period.
After measuring HIV prevalence in the screening phase, we
used bivariable logistic regression to assess determinants of
prevalent HIV infection; all factors associated with HIV-1
infection at p#0.10 in bivariable analyses were included in a
multivariable logistic regression model. We estimated HIV
incidence using the number of confirmed HIV seroconversions
per 100 woman-years (WY) of follow-up, and calculated the 95%
confidence interval (CI) of the incidence rate using exact methods
under the assumption that the number of HIV infections follows a
Poisson distribution. We used Cox regression analysis to calculate
HIV Prevalence & Incidence in Chókwè, Southern Mozambique
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bivariable and multivariable hazard ratios (HRs) and their 95%
CIs to evaluate the associations between incident HIV infection
and baseline characteristics and time-varying risk behaviors. All
data analyses were conducted using SAS version 9.3 (Cary, North
Carolina).
Ethical Considerations
The National Committee for Bioethics/Comité Nacional de
Bioética para a Saúde (CNBS) in Maputo, Mozambique, the FHI
360 Protection of Human Subjects Committee (PHSC), and the
Division of Human Subjects Protection (DHSP) of the Walter
Table 1. Baseline features of women entering Cross-sectional and Prospective Phases, Chókwè, Mozambique.
Cross-Sectional Phase N (%1) Prospective Phase N (%1)
1429 479
Age
Median (IQR) 23 (20–27) 22 (19–26)
18–24 864 (60.5) 323 (67.4)
25–29 369 (25.8) 115 (24.0)
30+ 196 (13.7) 41 (8.6)
Education
None 366 (25.6) 82 (17.1)
Primary school (grade 1–5) 438 (30.7) 139 (29.0)
Secondary school (grade 6–9) 439 (30.7) 175 (36.5)
High school and higher 186 (13.0) 83 (17.3)
Employment
Unemployed 767 (53.7) 248 (51.8)
Employed 147 (10.3) 52 (10.9)
Other 514 (36.0) 179 (37.4)
Missing 1 (0.1) –
Type of work
Office work, sales 285 (19.9) 86 (18.0)
Manual labor, food service 30 (2.1) 6 (1.3)
Student 150 (16.9) 125 (26.1)
Sex worker 2 (0.2) 0 (0.0)
Other 54 (3.8) 14 (2.9)
Missing 767 (53.7) 248 (51.8)
Marital status
Unmarried 762 (53.3) 234 (48.9)
Married 560 (39.2) 206 (43.0)
Other 107 (7.5) 39 (8.1)
Number of live births (mean (median)) 1.5 (1.0) 1.4 (1.0)
Number of sexual partners in the last 1 month
Median (IQR) 1 (1–2) 1 (1–2)
,2 778 (54.4) 322 (67.2)
2+ 651 (45.6) 157 (32.8)
Number of NEW sexual partners in the last 1 month
0 1226 (85.8) 441 (92.1)
1 164 (11.5) 31 (6.5)
2+ 39 (2.7) 7 (1.5)
Current contraceptive
None 740 (51.8) 219 (45.7)
Oral 298 (20.9) 108 (22.5)
Injectable 182 (12.7) 62 (12.9)
Condoms 198 (13.9) 89 (18.6)
Other/Missing 11 (0.8) 1 (0.2)
1Column percentage.
IQR = interquartile range.
doi:10.1371/journal.pone.0097547.t001
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Reed Army Institute of Research (WRAIR) reviewed and
approved the study protocol and other essential documents.
Written informed consent was obtained from all participants prior
to initiating study procedures.
Results
Study Population
The study screened 1,429 women in the cross-sectional
screening phase. 479 of the 1,009 HIV-negative women were
eligible and enrolled, and contributed HIV test data in the
prospective phase (enrollment ended at this point). We observed a
total of 373.1 WY of follow-up, with mean (median) of 9.4 (9.7)
women-months per participant. The overall completion rate,
including women who seroconverted, was 70.3%; 26.6% of the
women were lost to follow-up and 3.2% discontinued early.
More than half (60.5%) of women enrolled in the screening
phase were between 18–24 years old; the median age was 23
(Table 1). Educational attainment was modest, and over half
(53.7%) of the women were unemployed. Around one third
(39.2%) of the women were married. Nearly half (45.6%) reported
2 or more sexual partners in the last month, with a smaller number
(14.2%) reported having had a new sexual partner in the last
month. Half (51.8%) of the screening phase enrollees used no
contraception at baseline; the most commonly used method was
oral contraceptives (20.9%), and one in seven (13.9%) women
reported condoms as their contraceptive method. For all of the
above factors, the characteristics of the sub-set of women who
entered the prospective phase and contributed follow-up data
(N = 479) were similar (Table 1).
Prevalence of HIV in Cross-sectional Screening Phase
The prevalence of HIV was 29.4% (95% CI: 27.0–31.8%).
Older age was strongly associated with prevalent HIV infection in
bivariable analysis, as was lower educational attainment (Table 2).
Several sexual risk behaviors were associated with prevalent HIV,
including having multiple partners (OR: 2.0; 95% CI: 1.4–2.8; p,
0.001), a new partner in the last month (OR: 1.7; 95% CI: 1.2–2.3;
p = 0.001), and reporting vaginal sex without a condom in the last
7 days with a partner that was not considered primary (OR: 1.5;
95% 1.2–1.9; p,0.001). Using hormonal contraception or
condoms for contraception was associated with lower HIV
infection risk (OR: 0.6; 95% CI: 0.5–0.8; p,0.001 and OR 0.3;
95% CI: 0.2–0.5; p,0.001), respectively (Table 2). In multivar-
iable analysis, factors that remained statistically significant after
controlling for other variables included: older age (OR: 0.6; 95%
Table 2. Factors associated with prevalent HIV infection for women enrolled in the Cross-sectional Phase, Chókwè, Mozambique
(N= 1429).
Bivariable Analysis Multivariable Analysis
Odds Ratio (95% CI) p-value Odds Ratio (95% CI) p-value
Age
,= 24 0.5 (0.4, 0.6) ,0.001 0.6 (0.4, 0.7) ,0.001
.24 Reference Reference
Education
.=Grade 10 0.3 (0.2, 0.5) ,0.001 0.4 (0.3, 0.7) ,0.001
Grade,10 Reference Reference
Sex worker/transactional sex
Yes 1.5 (0.9, 2.4) 0.15
No Reference
.2 sex partners in last month
Yes 2.0 (1.4, 2.8) ,0.001 1.5 (1.0, 2.3) 0.07
No Reference Reference
New sex partner(s) last month
Yes 1.7 (1.2, 2.3) 0.001 1.2 (0.8, 1.7) 0.45
No Reference Reference
Vaginal sex without using condom in last 7 days with primary partner
Without using 0.9 (0.7, 1.1) 0.22
Using Reference
Vaginal sex without using condom in last 7 days with other partner
Without using 1.5 (1.2, 1.9) ,0.001 1.1 (0.9, 1.5) 0.43
Using Reference Reference
Baseline contraception
Hormonal method 0.6 (0.5, 0.8) ,0.001 0.6 (0.4, 0.7) ,0.001
Condom 0.3 (0.2, 0.5) ,0.001 0.5 (0.3, 0.7) ,0.001
Other 2.7 (0.8, 9.6) 0.13 3.2 (0.9, 12.2) 0.09
Nothing Reference Reference
doi:10.1371/journal.pone.0097547.t002
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CI: 0.4–0.7; p,0.001), lower educational level (OR: 0.4; 95% CI:
0.3–0.7; p,0.001), and using hormonal contraception (OR: 0.6;
95% CI: 0.4–0.7; p,0.001) or condoms (OR: 0.5; 95% CI: 0.3–
0.7; p,0.001).
HIV Incidence in Prospective Phase
We observed 17 seroconversions in the prospective cohort, an
overall HIV incidence rate of 4.6 per 100 WY of follow-up (95%
CI: 2.7, 7.3). The HIV incidence decreased slightly with age:
4.8 per 100 WY of follow-up (95% CI: 2.5, 8.3) in women aged
18–24 years; 4.5 per 100 WY of follow-up (95% CI: 1.2, 11.4) in
women aged 25–29 years; and 3.2 per 100 WY of follow-up (95%
CI: 0.1, 18.0) in the 30–35 years stratum.
When we examined factors associated with incident HIV
infection in Cox models, none of the variables was significantly
associated in bivariable analysis at the p#0.10 level (Table 3). We
therefore did not conduct a multivariable analysis. The direction
of the weak bivariable associations generally conformed to those
seen in the logistic regression findings for the screening phase.
Discussion
These data represent some of the first longitudinal HIV
incidence results from Mozambique. We detected a high HIV
prevalence (29.4%) and incidence (4.6 per 100 WY), despite
consistent risk reduction counseling and condom availability at
all study visits. Our findings confirm the magnitude of the HIV
epidemic in the southern region of Mozambique: the HIV
prevalence in the study is almost exactly the same as that found
in the last national surveillance survey among women aged 15–49
years old (29.9%) [2].
The HIV prevalence and incidence we measured in the
southern city of Chókwè were similar to those in a related study
conducted in the larger central Mozambican city of Beira [3–4],
although the Beira incidence rate was even higher at 6.5 per
100 WY [4]. A large prospective study of postpartum women in
southern Mozambique also found a substantial HIV incidence rate
of 3.2 per 100 WY overall, highest in the youngest women of 18–
19 years [5]. The incidence rate among participants in that study
from Gaza Province, where Chókwè is located, was slightly higher
at 3.6 per 100 WY.
Our study had several limitations. Foremost was the relatively
high loss to follow-up of 27%, despite vigorous tracing efforts.
Chókwè represented a particularly challenging environment for
retention activities, due to long distances to cover with the low
population density, and an episode of severe flooding during the
study. Besides travel obstacles, frequent reasons for missing follow-
up visits were concerns about the blood draws and partner
objection to participant return for HIV testing. Part-way through
the study, we revised the design to follow participants for as long as
24 months, and some women were indeed followed for more than
12 months (none for 24). But the study was terminated for
Table 3. Factors associated with incident HIV for women enrolled in the Prospective Phase, Chokwe, Mozambique (N = 479).
Bi-variable Analysis
Unadjusted HR (95% CI) p-value
Age 1.0 (0.9,1.1) 0.67
Education
$ Grade 10 0.6 (0.1,2.8) 0.56
,Grade 10 Reference
Sex worker/transactional sex
Yes 3.4 (0.5,25.9) 0.23
No Reference
Marital status
Yes 0.4 (0.1,1.2) 0.10
No Reference
New partner(s) in last month
Yes 0.7 (0.1,4.9) 0.68
No Reference
Vaginal sex without using condom in last 7 days with primary partner
without using 0.7 (0.3,1.8) 0.45
Using Reference
Vaginal sex without using condom in last 7 days with other partner
without using 2.5 (0.8,7.8) 0.10
Using Reference
Baseline contraception
Hormonal method 0.4 (0.1,1.3) 0.14
Condom 0.4 (0.1,2.0) 0.28
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PLOS ONE | www.plosone.org 5 May 2014 | Volume 9 | Issue 5 | e97547
financial reasons before most women could surpass 12 months,
and the mean and median woman-months of observation were 9
and 10 months respectively. Also, all participants who were
ultimately lost-to-follow-up made at least one visit and contributed
person-time and HIV data to the analysis.
Early study termination meant that we detected fewer new HIV
infections and had lower power to detect associations in the Cox
regression analyses. With 17 seroconversion events, we had power
to detect only strong associations, which likely explains our
inability to detect any factors significantly associated with new
HIV infection.
It may be that the Chókwè HIV epidemic is a highly complex
one associated with migrant labor patterns, placing all sexually
active women at higher risk for HIV acquisition. Although close to
one third of the study participants were married (36.8%), the HIV
epidemic in Chókwè cannot be discussed without taking the male
migrant labor pattern into account as this disrupts family
structures in Chókwè. The majority of Mozambican migrant
mineworkers, most of whom work in neighboring South Africa,
come from southern Mozambique, with approximately 40% of
them from Gaza province, mainly Xai-Xai (the provincial capital)
and Chókwè [6]. Other relevant factors that were outside the
scope of our study include a poor health care infrastructure,
widespread poverty, a lengthy civil war (1977 to 1992) and
proximity to countries with substantial HIV epidemics [7].
Our study found a high prevalence of multiple sexual
partnerships at screening (45.6%) and at prospective enrollment
(32.8%), defined as reporting more than one partner in the past
month. These data appear inconsistent with the national HIV
surveillance data, where 1% of women age 15–49 reported having
had two or more sexual partners in the past 12 months [2]. But by
design, our study aimed at recruiting women at higher risk for
HIV acquisition and focused recruitment on venues known for sex
exchanges (i.e. bars, markets, etc.). We found that baseline HIV
prevalence was associated with multiple partners (OR: 2.0) and
having had a new sexual partner in the last month (OR: 1.7).
Given the complexity of the HIV epidemic in Chókwè, it seems
likely that multiple partnerships help fuel HIV transmission,
especially against a backdrop of high HIV prevalence.
We also found low rates of condom use for family planning at
screening (13.9%) and at prospective enrollment (18.6%). These
data are similar to rates reported for the general population of
women aged 15–49 years old (9.5%) [2]. Fertility desires may
contribute to low condom use in this population [8]. Young
women wishing to become pregnant should be counseled on
approaches to reduce their risk of HIV infection. The data further
underscore the need for intensive HIV prevention programming
with individuals having multiple partners and low condom use in
Chókwè.
The study demonstrates a considerable HIV incidence in this
Mozambican city. The force of HIV infection remains strong in
those places in Mozambique where incidence has been measured
[4]. Our results point to the need for improved reproductive health
services, and more vigorous educational efforts and prevention
programming in Chókwè district.
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4. Dubé K, Zango A, van de Wijgert J, Meque I, Ferro JJ, et al. (2014) HIV
incidence in a cohort of women at higher risk in Beira, Mozambique:
prospective study 2009–2012. PLoS One 9(1): e84979.
5. De Schacht C, Mabunda N, Ferreira OC Jr, Ismael N, Calu N, et al. (2014)
High HIV incidence in the postpartum period sustains vertical transmission in
settings with generalized epidemics: a cohort study in Southern Mozambique.
J Int AIDS Soc 17: 18808.
6. Crush J, Raimundo I, Simelane H, Cau B, Dorey D (2010) Migration-induced
HIV and AIDS in Rural Mozambique and Swaziland. Migration Policy Series
N. 53, Southern African Migration Program. Cape Town, South Africa.
Available: http://www.queensu.ca/samp/sampresources/samppublications/
policyseries/Acrobat53.pdf. Accessed 12 September 2013.
7. Collins C (2006) Mozambique’s HIV/AIDS Pandemic: Grappling with




8. Speizer IS, White JS (2008) The unintended consequences of intended
pregnancies: youth, condom use and HIV transmission in Mozambique. AIDS
Educ Prevent 20: 531–546.
HIV Prevalence & Incidence in Chókwè, Southern Mozambique
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